Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 101 - 150 av 202 resultater
Tid
Selskap
Tittel
Sektor
Kategori
27 Feb 2023
07:30 CET
SENSORION
Sensorion renforce son équipe de direction avec la nomination de David Lawrence au poste de Directeur Financier
20103010 Biotechnology
New
27 Feb 2023
07:30 CET
SENSORION
Sensorion Further Strengthens Leadership, Appoints David Lawrence as Chief Financial Officer
20103010 Biotechnology
New
21 Feb 2023
07:30 CET
SENSORION
Sensorion announces R&D Day focusing on its Gene Therapy programs
20103010 Biotechnology
Meetings / events
21 Feb 2023
07:30 CET
SENSORION
Sensorion organise une journée R&D consacrée à ses programmes de thérapie génique
20103010 Biotechnology
Meetings / events
20 Feb 2023
07:30 CET
SENSORION
Sensorion Announces Its Financial Calendar for the First Half of 2023
20103010 Biotechnology
New
20 Feb 2023
07:30 CET
SENSORION
Sensorion publie son calendrier financier pour le premier semestre 2023
20103010 Biotechnology
New
02 Feb 2023
07:30 CET
SENSORION
Sensorion Will Present Two Posters atthe Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting
20103010 Biotechnology
Meetings / events
02 Feb 2023
07:30 CET
SENSORION
Sensorion présentera deux posters à la 46e rencontre annuelle de l’Association pour la Recherche en Otorhinolaryngologie (ARO)
20103010 Biotechnology
Meetings / events
31 Jan 2023
07:30 CET
SENSORION
Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear
20103010 Biotechnology
New
31 Jan 2023
07:30 CET
SENSORION
Sensorion et EVEON collaborent dans le cadre du développement d’un système d’injection pour l’administration de traitements de thérapie génique dans l’oreille interne
20103010 Biotechnology
New
05 Jan 2023
07:30 CET
SENSORION
Sensorion Will Take Part in a Press Conference Launching the Annual UNESCO Week of Sound
20103010 Biotechnology
Meetings / events
05 Jan 2023
07:30 CET
SENSORION
Sensorion participera à la conférence de presse de lancement de la Semaine du Son annuelle de l’UNESCO
20103010 Biotechnology
Meetings / events
03 Jan 2023
07:30 CET
SENSORION
Sensorion annonce le recrutement du premier patient dans l’essai clinique de preuve de concept de Phase 2a du SENS-401 dans l’ototoxicité induite par le cisplatine
20103010 Biotechnology
Other subject
03 Jan 2023
07:30 CET
SENSORION
SensorionAnnounces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
20103010 Biotechnology
Other subject
05 Dec 2022
07:30 CET
SENSORION
Sensorion annonce sa présence à la 41e Conférence annuelle J.P. Morgan Healthcare Meeting à San Francisco
20103010 Biotechnology
Meetings / events
05 Dec 2022
07:30 CET
SENSORION
Sensorion Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting in San Francisco
20103010 Biotechnology
Meetings / events
30 Nov 2022
07:30 CET
SENSORION
Sensorion reçoit la désignation de médicament orphelin de la Food and Drug Administration américaine pour OTOF-GT, pour le traitement de la perte auditive liée au gène de l’otoferline
20103010 Biotechnology
Other subject
30 Nov 2022
07:30 CET
SENSORION
Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration
20103010 Biotechnology
Other subject
09 Nov 2022
07:30 CET
SENSORION
Sensorion Will Attend In-Person the Jefferies London Healthcare Conference
20103010 Biotechnology
Meetings / events
09 Nov 2022
07:30 CET
SENSORION
Sensorion participera en personne à la conférence Jefferies London Healthcare Conference
20103010 Biotechnology
Meetings / events
07 Nov 2022
07:30 CET
SENSORION
Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss
20103010 Biotechnology
Other subject
07 Nov 2022
07:30 CET
SENSORION
Sensorion reçoit la désignation de maladie pédiatrique rare de la Food and Drug Administration américaine pour le traitement de la perte auditive liée au gène de l’otoferline
20103010 Biotechnology
Other subject
24 Oct 2022
07:30 CEST
SENSORION
SensorionAnnounces Approval to Initiate amended Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity in France
20103010 Biotechnology
Other subject
24 Oct 2022
07:30 CEST
SENSORION
Sensorion annonce l’approbation de l’amendement d’essai clinique de preuve de concept de Phase 2a du SENS-401 dans l’ototoxicité induite par le cisplatine en France
20103010 Biotechnology
Other subject
06 Oct 2022
07:30 CEST
SENSORION
Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022
20103010 Biotechnology
Meetings / events
06 Oct 2022
07:30 CEST
SENSORION
Sensorion participera aux conférences de la Société Européenne de la Thérapie Génique et Cellulaire (ESGCT) et à la Gene Therapy For Rare Disorders Europe en octobre 2022
20103010 Biotechnology
Meetings / events
26 Sep 2022
07:30 CEST
SENSORION
Sensorion to Participate in Various Upcoming Investor Conferences
20103010 Biotechnology
Meetings / events
26 Sep 2022
07:30 CEST
SENSORION
Sensorion participera à plusieurs rencontres investisseurs à venir
20103010 Biotechnology
Meetings / events
22 Sep 2022
07:30 CEST
SENSORION
Sensorion annonce ses résultats du premier semestre 2022
20103010 Biotechnology
Other subject
22 Sep 2022
07:30 CEST
SENSORION
Sensorion Reports 2022 First Half Results
20103010 Biotechnology
Other subject
14 Sep 2022
07:30 CEST
SENSORION
Sensorion annonce le recrutement du premier patient dans l’essai clinique de preuve de concept du SENS-401 pour la préservation de l’audition résiduelle suite à une implantation cochléaire
20103010 Biotechnology
Other subject
14 Sep 2022
07:30 CEST
SENSORION
SensorionAnnounces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
20103010 Biotechnology
Other subject
12 Sep 2022
07:30 CEST
SENSORION
Sensorion reçoit l’avis favorable de l’Agence Européenne des Médicaments pour la désignation de médicament orphelin pour OTOF-GT dans le traitement de la perte auditive liée au gène de l'otoferline
20103010 Biotechnology
Other subject
12 Sep 2022
07:30 CEST
SENSORION
Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss From the European Medicine Agency
20103010 Biotechnology
Other subject
08 Sep 2022
07:30 CEST
SENSORION
Sensorion to participate in the Inner Ear Biology Workshop in September 2022
20103010 Biotechnology
Meetings / events
08 Sep 2022
07:30 CEST
SENSORION
Sensorion participera à la conférence Inner Ear BIology Workshop, en septembre 2022
20103010 Biotechnology
Meetings / events
07 Jul 2022
07:30 CEST
SENSORION
Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022
20103010 Biotechnology
Meetings / events
07 Jul 2022
07:30 CEST
SENSORION
Sensorion participera aux conférences Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium et Cell & Gene Therapy Summit en juillet 2022
20103010 Biotechnology
Meetings / events
01 Jul 2022
07:30 CEST
SENSORION
SensorionAnnounces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
20103010 Biotechnology
Other subject
01 Jul 2022
07:30 CEST
SENSORION
Sensorion annonce l’approbation en Australie du lancement de l’essai clinique de preuve de concept du SENS-401 pour la préservation de l’audition résiduelle suite à une implantation cochléaire
20103010 Biotechnology
Other subject
24 Jun 2022
07:30 CEST
SENSORION
Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022
20103010 Biotechnology
Meetings / events
24 Jun 2022
07:30 CEST
SENSORION
Sensorion participera à la conférence LifeSci Partners 2nd Annual Genetic Medicines Symposiumle 29 juin 2022
20103010 Biotechnology
Meetings / events
15 Jun 2022
07:30 CEST
SENSORION
Sensorion to Present at the Inner Ear Disorder Therapeutics Summit in June 2022
20103010 Biotechnology
Meetings / events
15 Jun 2022
07:30 CEST
SENSORION
Sensorion participera à la conférence Inner Ear Disorder Therapeutics Summit en juin 2022
20103010 Biotechnology
Meetings / events
09 Jun 2022
07:30 CEST
SENSORION
Sensorion participera à la conférence Gene Therapy Development and Manufacturing en juin 2022
20103010 Biotechnology
Meetings / events
09 Jun 2022
07:30 CEST
SENSORION
Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022
20103010 Biotechnology
Meetings / events
07 Jun 2022
07:30 CEST
SENSORION
Sensorion annonce l’approbation en France du lancement de l’essai clinique de preuve de concept du SENS-401 pour la préservation de l’audition résiduelle suite à une implantation cochléaire
20103010 Biotechnology
Other subject
07 Jun 2022
07:30 CEST
SENSORION
SensorionAnnounces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
20103010 Biotechnology
Other subject
01 Jun 2022
07:30 CEST
SENSORION
Sensorion publie les résultats des résolutions de l’Assemblée Générale Mixte
20103010 Biotechnology
General meeting / Board Meeting
01 Jun 2022
07:30 CEST
SENSORION
Sensorion Publishes Results of Combined General Meeting Resolutions
20103010 Biotechnology
General meeting / Board Meeting
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
2
3
4
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva